February 6, 2013
While on the surface combining a dentist, your mouth, and high-powered lasers sounds like a nightmare, the propagation of that scenario is every BIOLASE (NASDAQ: BIOL ) investor's dream. In fact, the company behind the Waterlase dental laser system, which allows for essentially pain-free dental procedures, has just added a new FDA-cleared product to its roster.
In the following video, health care bureau chief Brenton Flynn runs through the news that has this stock surging, and outlines the large market opportunity that offers some amazing growth opportunity if the company can execute.
If you want exclusive, members-only analysis of the company behind another revolutionary medical technology, be sure to check out The Motley Fool's brand-new premium report on Intuitive Surgical.
A bearish research report has investors questioning the medical robotics company's future, and our analyst Karl Thiel recently released his exclusive take on the news. As one of the key minds behind our Rule Breakers recommendation of the stock in 2005 (before it went on to gain more than 1,000%), Thiel knows the Intuitive Surgical story inside and out. The report is a must-read for any current or prospective investor, and it comes with a full year of analyst updates. Be sure to claim your copy today by clicking here now.